{"version":"1.0","provider_name":"MELEMA Pharma GmbH","provider_url":"http:\/\/melemapharma.de\/en","author_name":"Prof. Dr. Hans Lentzen","author_url":"http:\/\/melemapharma.de\/en\/author\/h-lentzen\/","title":"Welcome to MELEMA Pharma - MELEMA Pharma GmbH","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"ck4UAnRcqm\"><a href=\"http:\/\/melemapharma.de\/en\/willkommen-bei-melema-pharma\/\">Welcome to MELEMA Pharma<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"http:\/\/melemapharma.de\/en\/willkommen-bei-melema-pharma\/embed\/#?secret=ck4UAnRcqm\" width=\"600\" height=\"338\" title=\"&#8220;Welcome to MELEMA Pharma&#8221; &#8212; MELEMA Pharma GmbH\" data-secret=\"ck4UAnRcqm\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=http:\/\/melemapharma.de\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","description":"MELEMA Pharma GmbH, a private biopharmaceutical company, is focusing on the development of immunotherapeutics having the potential to activate the patient\u2019s own immune system. A substantial medical challenge for the company is the immuno-oncology. The compounds under development are mainly based on natural compounds optimised by modern Gene Technological Procedures. Lead product is the immunepotentiator Aviscumine (ME-503), a therapeutic protein which recently completed a Phase II study in patients with refractory metastatic melanoma (stage IV) and for which the further clinical development is in preparation. MELEMA Pharma\u2019s strategy is to develop its drug candidates to Proof of Concept, and then bring in partners from academia and industry for the final stages of product development and commercialization."}